| Peripheral Primitive Neuroectodermal Tumor studied in …STUDIED_INderived21 of 21show fewer |
|---|
| → studied in | NCT06441331Phase 1 · recruiting Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02306161Phase 3 · active not recruiting Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04284774Phase 2 · active not recruiting Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04195555Phase 2 · active not recruiting Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04901702Phase 1/Phase 2 · recruiting Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06068075NA · active not recruiting Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213678Phase 2 · completed Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03213665Phase 2 · completed Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03526250Phase 2 · completed Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01231906Phase 3 · completed Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03220035Phase 2 · completed Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019578Phase 1 · completed Stereotactic Radiosurgery in Treating Patients With Brain Tumors · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00899990completed Collecting and Storing Biological Samples From Patients With Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Askin Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01217437Phase 2 · completed Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070109Phase 2 · completed Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00617890Phase 2 · terminated A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720) · condition mapped ALIAS · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00563680Phase 2 · completed QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors · condition mapped ALIAS · 21 trials mapped (9 active) | — | — | Askin Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00516295Phase 2 · completed Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Peripheral Primitive Neuroectodermal Tumor | 1 | Observed | clinicaltrials | graph → |